Advanced Energy Device
Tissue differentiation and vessel detection during dissection/sealing
Key Facts
About Briteseed
Briteseed is pioneering the integration of hyperspectral imaging into laparoscopic and robotic surgical instruments, aiming to reduce intraoperative complications by providing real-time, actionable tissue data. Founded in 2012 and based in Chicago, the company is developing a suite of smart tools, including advanced energy, stapler, and dissection devices, that work within current surgical workflows without requiring instrument swaps. Its core value proposition is enhancing surgeon decision-making by dynamically revealing anatomical structures and tissue quality that are not visible to the naked eye. As a private, pre-revenue company, Briteseed is positioned to address a significant unmet need in the growing minimally invasive and robotic surgery markets.
View full company profile